Bionano Genomics (BNGO) Research & Development (2017 - 2026)
Bionano Genomics (BNGO) posted Research & Development of $3.1 million for Q1 2026, down 2.79% sequentially from $3.2 million in Q4 2025, and up 32.45% YoY from $2.4 million in Q1 2025.
Bionano Genomics (BNGO) Research & Development (2017 - 2026) Analysis & Trends
Bionano Genomics has reported Research & Development for 10 years, with the latest figure at $3.1 million in Q1 2026.
- Quarterly Research & Development rose 32.45% year-over-year to $3.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.1 million (down 30.18% YoY) and the FY2025 annual result came in at $11.4 million, down 54.14% from the prior year.
- Research & Development fell to $3.1 million in Q1 2026 per BNGO's latest filing, from $3.2 million in the prior quarter.
- Over five years, Research & Development peaked at $14.6 million in Q2 2023 and troughed at $2.4 million in Q1 2025.
- A 5-year average of $8.4 million and a median of $9.8 million in 2024 frame the typical range for Research & Development.
- The sharpest annual moves came in 2022 and 2025: Research & Development surged 293.09% in 2022, then tumbled 75.76% in 2025.
- Over 5 years, Research & Development stood at $14.0 million in 2022, then declined by 16.49% to $11.7 million in 2023, then slumped by 70.31% to $3.5 million in 2024, then declined by 7.05% to $3.2 million in 2025, then fell by 2.79% to $3.1 million in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $3.1 million, $3.2 million, and $2.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 370.60 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 258.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 663.00 Mn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 105.73 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 19.70 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 178.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 42.50 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 129.00 Mn |
| 10 | Bionano Genomics | 14.03 Mn | 4.10 Mn | 4.31 Mn | 2.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.99 Mn |
| Mar 31, 2026 | 3.14 Mn |
| Dec 31, 2025 | 3.23 Mn |
| Sep 30, 2025 | 2.84 Mn |
| Jun 30, 2025 | 2.93 Mn |
| Mar 31, 2025 | 2.37 Mn |
| Dec 31, 2024 | 3.47 Mn |
| Sep 30, 2024 | 4.72 Mn |
| Jun 30, 2024 | 6.83 Mn |
| Mar 31, 2024 | 9.78 Mn |
| Dec 31, 2023 | 11.70 Mn |
| Sep 30, 2023 | 13.79 Mn |
| Jun 30, 2023 | 14.61 Mn |
| Mar 31, 2023 | 13.94 Mn |
| Dec 31, 2022 | 14.01 Mn |
| Sep 30, 2022 | 12.74 Mn |
| Jun 30, 2022 | 11.77 Mn |
| Mar 31, 2022 | 10.53 Mn |
| Dec 31, 2021 | 9.22 Mn |
| Sep 30, 2021 | 6.51 Mn |